Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-03-02 19:46:07
Reporting Period:
Filing Date:
Accepted Time:
2012-03-02 19:46:07
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
881464 Amylin Pharmaceuticals Inc AMLN Pharmaceutical Preparations (2834) 330266089
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236394 G Orville Kolterman 9360 Towne Centre Dr
San Diego CA 92121
Svp, Chief Medical Officer No Yes No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-03-01 1,846 $17.11 174,277 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,767 Indirect Indirect-401k
Common Stock 6,445 Indirect by ESOP
  1. Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of restricted stock units.
  2. Includes 941 shares recently acquired under the Company's Employee Stock Purchase Plan.
  3. These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.